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INTRODUCTION
Cryptopleurine inhibits protein synthesis in the yeast Saccharomyces
cerevisiae by prevention of amino acid incorporation into polypeptide, as
studied in yeast polysomes (1, 8, 12, 22). Polyuridylic acid directed
polyphenylalanine synthesis is inhibited by the drug in vitro (2, 4, 7,
8, 10, 22, 25). Resistance to cryptopleurine in yeast is due to a gene
cryl that has been mapped in the range of 2.1 to 4.2 cM proximal to the
mating type locus on chromosome III (7, 8, 16, 25). Skogerson, McLaughlin
and Wakatama (25) showed that ribosomes from cryptopleurine resistant
haploid mutant strains, carrying cryl , were more resistant to crypto-
pleurine in_ vitro than were ribosomes from sensitive haploid strains.
Meade, Riley and Manney (16) reported that diploid and higher
ploidy mutant strains of yeast did not demonstrate normal Mendelian
dominance-recessiveness relationships when assayed on agar plates con-
taining a gradient of cryptopleurine concentrations. Instead of finding
the mutant strains of the cryl locus to be recessive or dominant, they
observed that strains exhibited various sensitivities to cryptopleurine
which depended upon the ratio of cryl-7 resistant alleles to ploidy of
the strain. Thus their homozygous sensitive diploid strains were most
sensitive to cryptopleurine; homozygous resistant diploid strains were
most resistant; and heterozygous diploid strains were of intermediate
sensitivity. Unexpectedly, hemizygous diploid strains monosomic for
chromosome III, and therefore possessing only one cryl allele, also were
of intermediate sensitivity to cryptopleurine. Therefore, the expression
of resistance to cryptopleurine seems to be independent of the sensitive
1
allele. When the ratios of cryptopleurine resistance alleles to ploidy
equalled 1, the strains were most resistant, as measured by colony growth
on gradient agar plates. Strains possessing lower ratios (cryl alleles/
ploidy) displayed a proportionately lower resistance to cryptopleurine.
In order to investigate the effect of gene dosage on inhibition of
protein synthesis by cryptopleurine in yeast, experiments were performed
to measure the rates of protein synthesis in various cryptopleurine
resistant strains. Tests were also done to determine the sensitivity to
cryptopleurine in vitro of ribosomes from each strain.
Rates of protein synthesis were studied in diploid and monosomic
diploid spheroplasts by measuring the incorporation -of H-leucine into
acid precipitable peptide. Cell-free polyphenylalanine biosynthesis by
ribosomes isolated from the various strains was measured by incorporation
of H-phenylalanine into acid precipitable polypeptide. These experiments
determined the relative resistances to cryptopleurine of each strains'
•ribosomes and specifically determined if the monosomic diploid possessed
ribosomes that were resistant to cryptopleurine in vitro . Radioactive
protein synthesized in_ vivo and radioactive polyphenylalanine synthesized
in vitro were examined by polyacrylamide gel electrophoresis to determine
the sizes of polypeptide synthesized by each strain or its ribosomes in
the presence of cryptopleurine. It was expected that these data, along
with data that quantitate the rates of protein synthesis in_ vivo and in
vitro would aid in designing a genetic model that further characterizes
cryptopleurine resistance in yeast. A model is discussed that supports
the collected data and indicates further experiments.' This model sug-
gests the existence of a gene not on chromosome III whose gene product
interacts with the cryl gene product to effect the level of crypto-
pleurine resistance in yeast. 2
MATERIALS AND METHODS
Reagents
. Deacylated E. coli. B transfer ribonucleic acid (tRNA)
,
protein molecular weight markers, 3H-phenylalanine (54 Ci/mM) , and
H-leucine (48 Ci/mM) were obtained from Schwarz/Mann Laboratories.
Polyuridylic acid (poly U)
,
guanosine triphosphate (GTP) , N,N,N',N'-
tetramethylethylenediamine (TEMED) , and sodium dodecyl sulfate (SDS)
were purchased from Sigma. Adenosine triphosphate (ATP), acrylamide
and N,N' methylene bisacrylamide were produced by Eastman. Dextran
T-500 and Sephadex G-25 were obtained from Pharmacia Fine Chemicals
Inc.. Cryptopleurine (CRY) was purchased from Chemsea Manufacturing
Pty.
,
Ltd., Peakhurst, New South Wales, Australia. Liquifluor and
Protosol were obtained from New England Nuclear Corp.. Zymolyase was
a product of Kirin Brewery Co., Ltd., Takasake Gumma Pref
.
, Japan.
Glusulase and insulin were obtained from Endo Laboratories and Mann
Research Labs respectively. Components for media were purchased from
Difco. Additional reagents were obtained at highest purity available
from commercial sources.
Media
.
The culture media employed and their purposes are described
below. All ingredients were added to distilled water and sterilized in
the autoclave. Media were solidified with 20 g/1 agar.
YEPD. Difco Yeast Extract, 10 g/1; Difco Bacto Peptone, 20 g/1;
Dextrose, 20 g/1. YEPD is a rich complex medium used for routine cultur-
ing and stock maintenance (20)
.
YEPAD. YEPD with the addition of adenine at 80 mg/1, used for
maintenance of adenine auxotrophs.
MV. Difco Yeast Nitrogen Base without Amino Acids and ammonium
sulfate, 1.45 g/1; dextrose, 20 g/1; ammonium sulfate, 5.22 g/1.
Minimal medium was used to score nutritional reguirements (after
Wickerham (28)).
SC. MV supplemented as follows: adenine, 20 mg/1; arginine,
20 mg/1; histidine, 10 mg/1; leucine, 60 mg/1; lysine, 40 mg/1;
methionine, 20 mg/1; threonine, 350 mg/1; trytophan, 20 mg/1 (stock
solutions of tryptophan and threonine were filtered and the appropriate
amounts added aseptically after autoclaving) ; uracil, 20 mg/1. This
synthetic complete medium was used as a reference in the scoring of
nutritional phenotypes.
-X. SC lacking one or more of the supplements listed above; e.g.,
SC-leu is SC minus leucine. Omission media were used for scoring
nutritional phenotypes and as media for protein labeling with radio-
active leucine.
CRY. YEPAD plates supplemented with cryptopleurine dissolved in
95% ethanol and added to the autoclaved medium at a final concentration
of 5 UM. CRY was used to score resistance or sensitivity to crypto-
pleurine (16) .
PET. Difco Yeast Extract, 10 g/1; Difco Bacto Peptone, 10 g/1;
dextrose, 0.25 g/1; glycerol, 30 g/1. This medium was used to score
for the respiratory deficient (petite) phenotype.
BTBgal
.
Difco Yeast Extract, 10 g/1; Difco Bacto Peptone, 20 g/1;
galactose, 20 g/1; bromthymol blue (1% BTB in 95% ethanol), 33 g/1;
0.5 N NaOH (pH 8.0), 5 mg/1. This medium was used to score for the
ability to ferment galactose. When galactose is fermented, metabolic
4
acids cause BTB to change from blue-green to yellow within 24 hours.
YEKAC . Difco Yeast Extract, 2.5 g/1; potassium acetate, 10 g/1.
This was the sporulation medium (after McClary, Nulty and Miller (15)).
Incubation and growth. All incubations for growth and maintenance
of strains were at 30°C. When liquid media were used, the flasks con-
tained 20% of their nominal volume and were aerated by agitation on a
rotary platform shaker at 200 rpm. Yeast cells prepared for sphero-
plasting were grown in SC-leu medium and harvested at approximately
1 x 10 cells/ml. Yeast cells for preparation of ribosomes and S100
were grown in YEPD to a density of 2.5 x 107 cells/ml, harvested by
centrifugation at 10,000 x g and stored at -20°C until used.
Yeast strain's and nomenclature. The isolation of cryptopleurine
resistant yeast mutants and construction of diploid and monosomic diploid
strains used in these experiments have been described by Meade, Riley and
• Manney (16), and Riley and Manney (19). These strains and their geno-
types are summarized in Table 1. The genetic marker symbols are those
given by Plischke, VanBorstel, Mortimer and Chom (18) and are listed in
Appendix I. Those genes grouped by the underline reside in the order
given on the same linkage group (24) . For ease in designating the
cryl genotype of the strains, r will be used for the cryptopleurine
resistant allele, + for the wild-type sensitive allele, and o to designate
the missing chromosome III in aneuploid strains. The common genetic
background of these strains is indicated in Figure 1. The parent haploid
strains are XP300-26C (+) of mating type a and XP300-29B (+) of mating
type a. The cryptopleurine resistant haploid strain, CR7 (r) , is a
mutant isolated from XP300-26C (+) . Haploid yeast strains of opposite
5
Table 1. Strain list
Strain Genotype
XP300-29B + + MATa + hJj>6 Zy&l gal2 ade.2-1 #ip5-18
XP300-26C + + MATa tflAA hjjsb ly&l gal2
CR7 r Cu/1-7 MATa tlnfiJk kli>6 lyi>l gall
XP173 +/+ + MATa
+ MATa
+
#iA4
kli>6 lyi>\ gall
ha>h lyi>\ gal2
ade.2-1
+
t*p5-18
+
XT3428c r/+ cAj/1-7 MATa
+ MAT a
-t^.4
+
kii>6 lyi>\ gal2
ku>6 lyt>\ gall
+
ade.2-1
+
tfip5-18
XT3428c-48c r/r CAy1-7 MATa
CA^l-7 MAT a
thKk ku>6 lij&l gal2
+ ku>6 lyil gal2
+
ade.2-1
+
£tp5-18
XT3428c-48c-I r/o Cu/1-7 MATa thftA ki!>6 Itf&l gall
hue lyi>\ gall
+
ade.2-1
+
tnp5-lB
XJ33 r/r cAyl-7 MATa £fe/t4 ku>6 lyi>\ gall
kli>6 lyi>\ gall
+
ade.2-1
+
CAt/i-7 MATa + £tp5-18
Figure 1. Geneology of strains used in these studies,
showing common genetic background.
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mating type can mate to form diploid strains. The mating of XP300-26C
(+) and XP300-29B (+) yielded the homozygous sensitive strain XP173 (+/+);
mating of XP300-29B (+) and CR7 (r) yielded the heterozygous strain
XT3428C (r/+)
.
The homozygous resistant strain XJ33 (r/r) was derived
from the heterozygous diploid strain by mitotic gene conversion at the
cryl locus. Another homozygous resistant strain XT3428C-48C (r/r) was
derived from the heterozygous strain, presumably through mitotic crossing
over at the mating type locus and mitotic gene conversion at the cryl
locus. The monosomic diploid XT3428C-48C-I (r/o) was derived from the
homozygous resistant strain XT3428C-48C (r/r) through loss of chromosome III,
The tester strains used to confirm the mutant strains' genotypes
were derived from strains obtained from R.K. Mortimer (University of
California, Berkeley). These strains and their genotypes are listed in
Table 2. The two strains, XT1219-1A and XT1219-18A were used to determine
the mating types of the spores. These test strains were deficient for
galactose fermentation at the gall locus and the spores that were tested
were deficient at the ga!2 locus. When a haploid spore was cross-
streaked with each of these strains, it was able to mate with the strain
of opposite mating type and the galactose fermentation deficiencies of
each strain were complemented by the other strain. Thus, the diploid
progeny of the mating were able to ferment galactose changing the BTB
medium to yellow. When a haploid spore mated with XT1219-1A, of mating
type a, then the haploid spore was of mating type a.
The strains X1069-2D and S1795A were used to determine nutritional
deficiencies in diploid spores. These test strains carry the histidine
auxotrophy at the his4 locus while the spores that were tested carried
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the histidine auxotrophy at the his6 locus. The diploid spores were
cross-streaked with each of these strains and if the spores were able
to mate (i.e., not of mating type a/a) they mated with the test strain
of opposite mating type. When each strains' histidine requirements were
complemented, the progeny of the mating were able to grow on SC-his
medium.
Since the r/o strain possessed only one mating type locus on
chromosome III, it could not sporulate to form a tetrad. A cryptopleurine
resistant diploid strain was isolated to mate with the r/o strain and
form a tetraploid strain that could sporulate. The cryptopleurine
resistant strain X1069-2D-CR was isolated from the sensitive strain
X1069-2D. The strain subsequently was crossed with the strain XT1172-22C
to form a strain heterozygous for both mating types (a/a) and crypto-
pleurine resistance (r/+)
.
Mitotic crossing over between the centromere
and the cryl-7 locus yielded XP1069, a strain homozygous for crypto-
pleurine resistance and the a mating type. XP1069 was crossed with the
r/o strain to form a tetraploid strain that was sporulated and used to
confirm the genotype of the r/o strain.
Genetic Analysis
. The genotypes of the three normal diploid
strains (r/r, r/+ and +/+) were confirmed by tetrad analysis. The
strains were grown for 24 hours on YEPAD plates for presporulation
growth, transferred to YEKAC plates and incubated 3 to 4 days. Sporu-
lation occurred and asci were dissected by the method of Johnston and
Mortimer (12). The sporulation mixture was treated with a 1:20 dilution
of glusulase for 12 minutes and a small amount of the mixture was spread
along the edge of a thin YEPAD agar slab with a loop. The four spores
11
from each of the asci were isolated by micromanipulation, incubated for
2 to 4 days on YEPAD plates, and transferred to YEPAD master plates. The
master plates containing individual spores were scored for nutritional
phenotype by replica plating to appropriate media. As a test for mating
type, each spore was cross-streaked with the tester strains XT1219-1A
and XT1219-18A, incubated for 24 hours, and replica plated to MV or
BTBgal agar plates. Each of the disomic diploid strains produced tetrads
with the expected nutritional segregation frequencies.
The genotype of the monosomic diploid (r/o) was verified by mating
it with the diploid strain XP1069 and isolating a zygote diploid which
was then sporulated and dissected giving diploid spores. The spores
were tested for nutritional phenotype by replica plating. They were
cross streaked with XT1219-1A and XT1219-18A to determine mating type.
Since these were diploid spores, heterozygous spores (a/a) were non-
maters. Each of the spores was also cross streaked with the histidine
auxotrophs X1069-2D and S1795A to determine nutritional phenotypes.
The spores were scored for sporulation on YEKAC agar plates by micro-
scopic examination to determine whether nonmating spores were sporu-
lators. The results of sporulation tests in conjunction with the mating
type tests and thr4 segregation frequencies were used to eliminate false
asci. Only data from tetrads with four germinated spores were analyzed.
All the isolated diploid spores showed the expected ratios of nutritional
phenotypes, mating types and sporulation.
Preparation of spheroplasts . The spheroplast technique used was
a modification by T.R. Manney and R. Corfman (personal communication) of
the technique used by Hartwell (9) . The cells were harvested by centri-
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fugation at 1,500 x g for 5 minutes. They were resuspended in deionized-
distilled water and centrifuged as before in a graduated conical centri-
fuge tube. The volume of cells was converted to weight of cells (there
are approximately 0.98 grams yeast cells per milliliter of packed cells)
.
The cells were suspended in an osmotically supportive buffer solution
containing 0.6 M mannitol and 0.01' M potassium phosphate (pH 7.0).
Approximately 5 mis buffer per 0.1 gms cells was enough to suspend the
cells. The cell number was measured by counting samples with a Coulter
Counter (Model Zf , 100 ym aperature) after sonication for 10 seconds
and dilution in 0.85% NaCl. The 5 ml samples of suspended cells were
mixed with 0.1 ml 2-mercaptoethanol and zymolyase stock solution was
added at a level of 50 mg enzyme per gram cells. The zymolase stock
solution was prepared by dissolving the enzyme at 10 mg/ml in 0.1 M
potassium phosphate buffer (pH 7.0) and 0.6 M mannitol. The reaction
mixtures were incubated at 22°C on a rotary platform shaker at 200 rpm
for one hour. Spheroplasts were centrifuged at 1*500 x g for 5 minutes,
washed in the same buffer (0.6 M mannitol and 0.01 M potassium phosphate
(pH 7.0)) and recentrifuged. The spheroplasts then were suspended in
SC-leu containing 0.6 M mannitol and 0.01 potassium phosphate (pH 7.0)
at 5 x 10 spheroplasts/ml. Untreated cells and spheroplasts were
diluted in 0.85% NaCl and plated on YEPAD at 250 cells per plate and
500 cells per plate respectively. Plating efficiency was 75% for cells
and 0.02% for spheroplasts. Therefore, approximately 99.98% of the
yeast were rendered spheroplasts by this procedure.
Protein synthesis in spheroplasts. The time required for sphero-
plasts to resume protein synthesis after treatment with mercaptoethanol
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and zymolyase was determined by incubating spheroplasts from the sensi-
tive diploid for various times at 30°C followed by a 10 minute pulse
of JH-leucine (48 Ci/mM) to determine the rate of protein synthesis.
Reactions of 1 ml contained 5 x 10' spheroplasts in growth media (SC-leu
plus 0.6 M mannitol and 0.01 M potassium phosphate (pH 7.0)). After
incubation in a shaker bath at 30°C for the times indicated, 1 UCi
•^H-Leu was added to duplicate 1 ml samples. After an additional 10
minutes, the reactions were terminated by addition of SDS (1% w/v) and
trichloroacetic acid (10% w/v) , they were heated at 90°C for 15 minutes
and then incubated in an ice water bath for 15 minutes. Acid precipitable
proteins were collected on glass fiber filters, and radioactive proteins
were assayed in a liquid scintillation counter. The rate of protein
synthesis in spheroplasts increased rapidly during the initial 10 minutes
after return to 30°C and reached a plateau by approximately 30 minutes
as shown in Figure 2. Protein synthesis depended upon incubation at
30°C, since control samples that were retained at 4°C for up to 60
minutes did not incorporate radioactivity (open circles in Figure 2)
.
Based upon this experiment, 30 minutes at 30°C was chosen for a standard
preincubation of spheroplasts in further experiments.
In order to determine the time period necessary for cryptopleurine
to inhibit protein synthesis, the drug was added in the range of 1 x 10~ 5
to 1 x 10 M to spheroplast reaction samples as before. One set of
samples was incubated for 15 minutes, inhibited with the drug for 15
minutes and pulse labeled with 1 UCi H-leucine for 10 minutes. The
other set of samples was incubated for 25 minutes, inhibited by the
drug for 5 minutes and pulse labeled with 1 UCi 3H-leucine for 10
14
Figure 2. The rates of 3H-leucine incorporation into protein in yeast
spheroplasts. Spheroplasts of the +/+ strain were incubated
at 30°C for the time periods indicated and then were pulse
labeled for 10 min. with 3H-Leu. Trichloroacetic acid
precipitated radioactivity was measured in spheroplast
lysates. Symbols: (f) incubation and pulse labeling at
30°C and (Q) incubation and pulse labeling at 0°C.
15
10 20 30 40 50
TIME (MINUTES)
60
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minutes. The reaction samples were terminated and assayed as previously
described. The two drug incubation time periods produced equivalent
inhibitions of spheroplast protein synthesis. A 5 minute incubation
time with cryptopleurine was chosen for further experiments since the
drug sufficiently inhibited spheroplast protein synthesis in that time
period.
The effects of cryptopleurine on protein synthesis were determined
in reactions that contained spheroplasts from various strains in 1 ml
of the same growth media. After incubation at 30°C for 25 minutes,
-7
cryptopleurine was added to the samples at concentrations from 1 x 10
to 1 x 10~ M for 5 minutes. The samples were then pulse labeled for
10 minutes with 1 UCi of ^H-Leu and were processed as described above.
Reaction mixtures analyzed by gel electrophoresis were identical
to the above samples, except that they were pulse labeled with 5 UCi/ml
3H-Leu for 20 minutes at 30°C. After chilling the mixtures on ice,
the spheroplasts were harvested by centrifugation, lysed in 0.1 M NaOH,
incubated at 37 °C for 30 minutes and neutralized with HC1.
Preparation of 3H-Phe-tRNA. The optimal conditions for
aminoacylating tRNA were (in 15 ml): 0.3 M Tris hydrochloride (pH 8.1);
0.01 M KC1; 0.02 M magnesium acetate; 0.01 M ATP; 1635 A260 units tRNA;
25 mg dialyzed dextran phase yeast protein (25); and 2.92 mCi of ^H-Phe.
The 3H-Phe was prepared in a 40 ml conical tube and all reagents except
the dialyzed protein were added and mixed at 37°C for 5 minutes for
equilibration. The reaction was initiated by addition of the dialyzed
protein fraction and incubated at 37°C for 30 minutes. One tenth volume
of 1.0 N sodium acetate (pH 5.0) was added on ice to the solution to
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stabilize the aminoacyl-tRNA. The solution was mixed gently with an
equal volume of phenol on ice for 10 minutes and centrifuged at 1,500 x g
for 5 minutes. The aminoacylated tRNA was removed in the upper aqueous
phase, and the remaining phenol phase was re'extracted with buffer. The
pooled aqueous phases were chromatographed on a G-25 medium column in
1.0 mM sodium acetate (pH 5.0) to remove free 3H-Phe. From each column
fraction 20 pi was precipitated with 10 ml of 5% trichloroacetic acid
(TCA) and 5 ml of 0.01 N HCl to determine the amount of acid precipitable
^H-Phe-tRNA. Radioactivity was determined by using Liquifluor scintillation
fluid in a scintillation counter at 22% efficiency. The fractions with
3 H"-Phe-tRNA were pooled and lyophilyzed. The lyophilyzed H-Phe-tRNA
samples were stored desicated at -20°C. The efficiency of amino-acylation
3
was generally 0.4 to 0.5% (pmole H-Phe/pmole tRNA) in these preparations.
Preparation of ribosomes and elongation factors. Elongation factors
(S100) and ribosomes were prepared by the dextran-polyethylene glycol two
phase extraction procedure of Skogerson, McLaughlin and Wakatama (25)
.
Development of polyphenylalanine synthesis assay. Cryptopleurine
is insoluable in water and thus was dissolved at a concentration of 0.02 M
in 95% ethanol. To solubilize the drug, acetic acid was added also to
0.02 M. Then the solution was diluted in water to 1 x 10~ M and
neutralized with NaOH. Cryptopleurine concentrations were measured
using the extinction coefficient of 5.75 x 10 l/cm»mole, at 258 nm (3).
Since there was residual ethanol and acetic acid in dilute cryptopleurine
solutions, the same concentration of ethanol and acetic acid always
were used in control experiments. The rate of polyphenylalanine
synthesis in reactions containing this solvent alone (i.e., acetic acid
18
and ethanol) was unaffected by solvent to a concentration of 1 x 10 M
acetic acid (see Figure 3). At a concentration of 5 x 10 M the solvent
itself inhibited polyphenylalanine synthesis by over 90%. This assay
was therefore restricted to solvent or cryptopleurine concentrations of
1 x 10 M or less. The percent ribosome activities for reactions that
contained cryptopleurine were computed by the formula:
/ control cpm - cryptopleurine cpm \
control cpm
Confidence limits in experimental data were determined by the Student
T-test and by use of ttye standard deviation.
Polyphenylalanine synthesis. Reaction mixtures contained in
0.1 ml: 0.05 M Tris acetate (pH 7.0); 0.05 M NH4C1; 0.02 M
dithiothreitol (DTT) ; 0.08 M MgCl2 ; 0.494 A26Q units of poly U; 0.001 M
GTP; 33 Ug of dialyzed S100 protein from the (+/+) strain; 0.2 A260
units of ribosomes; 6 pmole of 3H-Phe-tRNA: and the indicated concen-
tration of cryptopleurine. These conditions gave optimal concentrations
for all reagents except for the amount of ribosomes which was limiting.
After incubation for 15 minutes at 37°C, reactions were terminated by
the addition of 0.5 ml of 10% TCA, heated at 90°C for 15 minutes and
quickly cooled by addition of 1 ml cold 10% TCA. After 15 minutes on
ice, the samples were filtered and assayed as described above.
Reaction mixtures analyzed by polyacrylamide gel electrophoresis
were as above but their volumes were five times larger (i.e., 0.5 ml).
After an incubation for one hour at 37 °C, these reactions were terminated
by the addition of NaOH to a final concentration of 0.1 M and incubated
at 37°C for an additional 30 minutes. The samples were neutralized with
1 M HC1 and lyophilyzed.
19
Figure 3. Inhibition of polyphenylalanine synthesis by cryptopleurine
in solvent and by solvent (ethanol + acetic acid) alone.
Cryptopleurine inhibited ribosomes from (0) +/+ and from
() r/r. Solvent inhibited ribosomes from (O) +/+ and
from O) r/r. All points were determined by duplicate
reaction mixtures and the error bars indicated are two
standard deviations.
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Polyacrylamide gel electrophoresis
.
The molecular weights of the
3protein products synthesized by spheroplasts and of H-polyphenylalanine
whose synthesis in_ vitro was directed by poly U were analyzed by
Laemmli's method of sodium dodecyl sulfate (SDS) polyacrylamide gel
electrophoresis (14) . The apparatus was assembled and the bottom of
gel tubes or slabs were covered with Parafilm to support the gels during
polymerization. Gels containing 4 or 5% (stacking gels) and 15 or 20%
(resolving gels) acrylamide were prepared from a stock solution of 30%
by weight and 0.8% by weight of N,N* bis-methylene acrylamide. Buffers
in the resolving gel were 0.375 H Tris hydrochloride (pH 8.8) and 0.1%
SDS. The above mixture was degassed under vacuum for 3 minutes and
polymerized by the addition of 0.025% by volume of tetramethylethylenedia-
mine (TEMED) and ammonium persulfate. The mixture was quickly poured
into glass tubes for 10 cm tube gels or between vertical glass plates
to form a 10 cm slab gel and were overlaid gently with water to polymerize
for one hour. The 4 or 5% stacking gels contained 0.125 M Tris hydro-
chloride (pH 6.8) and 0.1% SDS and were polymerized by the same method
as for the resolving gel. The water was removed from the top of the
resolving gel and the stacking gel was poured over the resolving gel to
a depth of 1 cm and allowed to polymerize for 30 minutes to one hour.
Protein molecular weight (MW) standards used to calibrate the gels
were bovine serium albumin (BSA) , MW 65,400 daltons; ovalbumin (OV)
,
MW 45,000 daltons; chymotrypsinogen (CHY) , MW 25,000 daltons; cytochrome
C (CYT C) , MW 13,400 daltons; insulin (I), 5,700 daltons. The molecular
weight standards were dissolved in a dye solution containing 0.057 M
Tris hydrochloride (pH 6.8); 0.001% bromphenol blue (BPB) ; 1.83% SDS.;
22
10.83% glycerol; 1.33 M urea; 0.017% acetic acid; 0.017% basic fuscin;
and 0.917% 2-mercaptoethanol. Each protein standard was added at a
final concentration of 4 to 5 Ug per gel.
The gels were placed in the electrophoresis chamber filled with the
electrode buffer (pH 8.3) containing 0.025 M Tris, 0.192 M glycine; and
0.1% SDS. Electrophoresis samples were dissolved in a small volume of
electrophoresis buffer containing 0.0625 M Tris hydrochloride (pH 6.8);
1 M 2-mercaptoethanol; 0.001% bromphenol blue; 2% SDS; and 10% glycerol
and heated in a boiling water bath for three minutes. Samples were
loaded into the gel sample wells, and electrophoresis was carried out
with a current of 5 mA per gel (tube gels) or 40 mA (slab gels) until
the BPB marker was 0.5 cm from the bottom of the gel (about five hours).
The gels were removed from the glass using water pressure from a 10 ml
syringe. The gels containing molecular weight standards were stained
overnight in a 0.2% Coomassie brillant blue, 50% methanol and 10% TCA.
They were destained for 5 hours at 37°C in 50% methanol and 10% TCA
and diffusion-destained by repeated washings in 10% methanol and 10%
TCA. When protein bands were visible, the positions of bands and
the total gel length were recorded. The remaining gels were frozen,
fractionated into 2 mm slices, and placed into Liquifluor scintillation
fluid containing 3% Protosol. The sample slices were heated for 12
hours at 37°C to promote release of proteins from the gel. Yields of
radioactivity were analyzed in a LS-100C Beckman scintillation counter
at 22% efficiency.
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RESULTS
Cryptopleurine resistance in spheroplasts. Meade, Riley and
Manney (16) observed that yeast strains possessing different ratios of
cryptopleurine-resistance alleles to ploidy demonstrated different
sensitivities to cryptopleurine on agar plates containing a gradient of
cryptopleurine concentrations. They found that resistance to the drug
increased in proportion to that ratio, and that the monosomic diploid
strain (r/o) hemizygous for the resistant allele was as sensitive to the
drug as was the heterozygous strain (r/+) . To confirm that cryptopleurine
inhibits protein synthesis and to better quantitate resistance of the
various strains to the drug, ratios of protein synthesis were analyzed
in spheroplasts treated with cryptopleurine.
Spheroplasts prepared from several yeast strains, both sensitive
and resistant to cryptopleurine, were used to determine the effect of
cryptopleurine on their rates of protein synthesis as described in
Methods. The effects of cryptopleurine on several strains are shown
-7
in Figure 4. Rates of protein synthesis in the presence of 5 x 10 M
cryptopleurine were also measured in six identical samples of sphero-
plasts from each diploid yeast strain to verify their relative sensi-
tivities to the drug. The results are presented in Table 3.
From Figure 4 one observes that the r/r diploid and r haploid
strains were more resistant than the diploid r/+ and monosomic diploid
r/o strains. The r/+ and r/o strains were more resistant than the
sensitive diploid +/+ and haploid + strains. The concentrations of
cryptopleurine required for 50% inhibition of protein synthesis were
24
Figure 4. Inhibition of spheroplast protein synthesis by cryptopleurine.
Details of this assay are given in the text. Data points at
5 x 10 m cryptopleurine have 7 d.f. while all other data was
derived from duplicate reactions. Symbols: (#) +/+, (Q + ,
m r/o, A r/+, O r, r/r.
25
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Table 3. Sensitivity of yeast spheroplasts to
cryptopleruine (5 x 10"' M)
r/r
r/+
r/o
+/+
3HT-leucine incorporated
cpm/10 min. pulse
Genotype Solvent along +cryptopleurine Activity remaining %
64376 + 4610* 58666 + 5564*
49685 + 7528 19119 + 915
59446 + 5006 17134 + 656
71305 + 6805 6659 + 180
91.1 + 8.5*
38.5 + 1-8
28.8 + 1.0
9.3 + 0.0
*95% confidence limits based upon the t-test using 5 d.f
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approximately forty-fold higher in the r/r and r resistant strains than
in the r/+ and r/o strains. The concentrations of cryptopleurine required
for the equivalent inhibitions were approximately three fold higher for
the r/+ and r/o than for the +/+ and + strains. These data are summarized
in Table 4 where the ratios of cryptopleurine resistant alleles to ploidy
also are indicated. The results of the replicate tests that contained
5 x 10-7 m cryptopleurine as tabulated in Table 3 are comparable to the
data presented in Figure 4 and indicate the same order of resistance by
the various strains to cryptopleurine. These results agree with the
relative sensitivities for growth observed by Meade, Riley and Manney
on gradient agar plates (16) . Strains possessing a ratio of 1 (r/r and
r) were most resistant, strains with a ratio of h (r/+ and r/o) were of
intermediate resistance and strains with a ratio of were most sensi-
tive.
The size of proteins synthesized by spheroplasts in the presence
of cryptopleurine. Cryptopleurine inhibits elongation of polyphenyl-
alanine peptide (25), and one might expect that ribosomes from resistant
strains would allow elongation to procede while ribosomes from sensitive
strains would block progression of both resistant and sensitive ribosomes
during their progression along the mRNA. Thus one expectation was that
the yeast strain possessing only resistant ribosomes (r/r and r/o) would
synthesize longer proteins in the presence of cryptopleurine while the
heterozygous diploid (r/+) would synthesize only shorter polypeptides.
The sizes of proteins synthesized in spheroplasts from the four
diploid strains in the presence of cryptopleurine was investigated by
— ft
gel electrophoresis. The concentration of cryptopleurine was 1 x 10 m,
28
Table 4. Inhibition of protein biosynthesis in yeast
spheroplasts.
Yeast strain CA.t/1-7 alleles/ploidy Cryptopleurine
genotype cone ID5Q
yM*
r
r/r 2:2= 1 9.2
1:1= 1 7.8
r/+ 1:2= h 0.28
r/o 1:2= h 0.165
+/+ 0:2= 0.075
+ 0:2- 0.054
* Inhibitory Dose that causes 50% inhibition of the
rate of protein biosynthesis.
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since that concentration best distinguished between resistant and sensi-
tive strains (see Figure 4) . The electrophoretic patterns of proteins
labeled with 3H-Leu are illustrated in Figure 5. Migration of several
standard proteins also is indicated at the top of the figure.
Spheroplasts from each diploid strain synthesized 3H-labeled
proteins that were hetergeneous in size. The proteins varied in size
between 10,000 and 65,000 daltons with a molecular weight peak in the
range of 21,000 daltons. As is apparent in Figure 5, spheroplasts from
the three diploid strains possessing at least one r allele (r/r, r/o
and r/+) all synthesized proteins that could not be distinguished on
the basis of molecular weight. Spheroplasts from the three strains
possessing r alleles also synthesized more protein than did the sensi-
tive diploid strain (+/+) • Since the r/+ spheroplasts synthesized pro-
teins of the same size and amount as the strains containing only r
alleles, the results of these experiments suggest that sensitive ribosomes
are not blocking the progression of resistant ribosomes along mRNAs.
Therefore, if sensitive ribosomes are formed, it appears that crypto-
pleurine may inhibit the binding of sensitive ribosomes to polysomes
as well as their progression along the message.
Ribosomes and S100 yields. Several investigators (2, 4, 7, 8, 10,
22, 25) have reported the ribosome to be the site of cryptopleurine
resistance in haploids. If resistance to cryptopleurine depends on the
number of resistant ribosomes per cell then one might expect the r/+ and
r/o strains to possess equal resistance to the drug if ribosome con-
centrations are regulated by a locus on chromosome III. The diploid
resistant strain (r/r) would possess more resistant ribosomes than the
30
Figure 5. Electrophoresis of ^H^proteins synthesized by spheroplasts.
The samples were prepared and analyzed by polyacrylamide
gel electrophoresis as described in the text. The electro-
phoretic mobility of the standard proteins are indicated at
the top: bovine serum albumin (BSA) , 65,000 daltons ,-
ovalbumin (OV) , 45,000 daltons; chymotrypsinogen (CHY)
,
25,000 daltons; cytochrome C (CYT C) , 13,400 daltons. The
total number of 3H-cpm incorporated by the spheroplast
samples were for +/+, 1.06 x 10 (#) ,- for r/r, 2.23 x 10 <) ;
for r/+ 1.83 x 105 (A); and for r/o, 2.15 x 105 #) .
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r/+ and r/o strains and thus would be more resistant to cryptopleurine
as was shown in spheroplasts (see Figure 4) . Yields of ribosomes and
SlOO's were analyzed to determine if strain differences in yield among
the strains might correlate with the patterns of resistances to crypto-
pleurine.
Ribosomes and elongation factors (S100) were prepared from the
four diploid strains as described above. The yields of these components
from each strain are summarized in Table 5. From the data in Table 5,
it is apparent that the monosomic diploid strain (r/o) yielded somewhat
fewer ribosomes than did the sensitive strain (+/+)• and resistant strain
(r/r) , but only slightly less than did the heterozygous strain (r/+)
.
Yields of S100 proteins from all the strains were comparable. The r/o
strain produced approximately 76% as many ribosomes as did the r/r
strain and 87% as many ribosomes as did the r/+ strain. If the
.
resistance to cryptopleurine is proportional to the number of resistant
ribosomes per cell, then the r/o strain should be 76% as resistant as
the r/r strain and more resistant than the r/+, which has only a portion
of its ribosomes that are resistant. Thus differences in ribosome
yield and thus resistant ribosome content do not account for the r/o
strain's lower sensitivity to cryptopleurine.
Cryptopleurine resistance of ribosomes in polyphenylalanine
synthesis . Skogerson, McLaughlin and Wakatama (25) found the ribosome
to be the site of cryptopleurine resistance in mutant haploid strains.
Others (7, 22) observed that ribosomes from heterozygous diploid strains
(r/+) possessed intermediate resistances to cryptopleurine.
^H^polyphenylalanine synthesis was assayed with ribosomes prepared
33
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from each of the four diploid strains to determine if ribosomes from
these strains showed similar sensitivities to cryptopleurine or if the
ribosomes* sensitivities reflected the properties observed in sphero-
plasts. 3H-polyphenylalanine synthesis was assayed as described above
using elongation factors (S100) from the sensitive strain (+/+)- A
comparison of the effects of cryptopleurine on polyphenylalanine
synthesis using ribosomes from the four diploid strains is presented
in Figure 6. The cryptopleurine concentrations necessary to inhibit
3H-polyphenylalanine synthesis in vitro were considerably higher than
those necessary to inhibit protein synthesis in living spheroplasts.
Ribosomes from the strains that possessed at least one resistant allele
(r/r, r/o and r/+)- were indistinguishable from each other by this assay
and were more resistant to cryptopleurine than were ribosomes from the
sensitive strain (+/+) . The concentration of cryptopleurine required
for 50% inhibition of polyphenylalanine synthesis was approximately
2x higher for all the strains that contained at least one resistant
allele than for the diploid sensitive strain (+/+) • Thus strains that
possessed at least one r allele produced ribosomes that were more re-
sistant to cryptopleurine in_ vitro .
To determine if ribosomes from the resistant strain tested were
causing the same amount of 3n-Phe incorporation into 3n-polyphenylalanine
in the presence of cryptopleurine as in the absence of the drug, yields
of polyphenylalanine produced per ribosome ( 3H-Phe pmoles per A2^q of
ribosomes) were computed from the data pf Figure 6 at a cryptopleurine
-5
concentration of 5 x 10 M (see Table 6) . Each of the strains incor-
porated equivalent amounts of 3H-Phe into polyphenylalanine in the
35
Figure 6. Inhibition of polyphenylalanine synthesis by cryptopleurine.
Ribosomes were prepared from: +/+ (£) , r/r () , r/+ (A) ,
and r/o (£)) . Polyphenylalanine synthesis was carried out
in 8 replicate reactions for 15 min. in the presence of
various concentrations of cryptopleurine as described in
the text. Only elongation factors from the sensitive
strain, +/+, were used. The error bars indicate 90%
confidence limits on the data as calculated from the t-
test, d.f.=7.
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Table 6. Polyphenylalanine produced per ribosome
in polyphenylalanine synthesis*
3(pmole H--phe/A26Q r
ibosomes/15 min.)
Strain + cryptopleurine 5 x 10~
7
M solvent alone
r/r 16.3 28.9
r/o 17.9 30.3
r/+ 19.8 30.7
+/+ 11.7 30.2
Determined from data of Figure 6 at 5 x 10" M cryptopleurine
concentration.
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absence of the drug indicating that all populations of ribosomes tested
were equally active. In the presence of cryptopleurine, ribosomes from
the diploid strains possessing at least one r allele (r/r, r/o and r/+)
were inhibited approximately 40% while ribosomes from the sensitive
diploid strain was inhibited by approximately 60%
.
Gel electrophoresis of 3H-polyphenylalanine
.
Electrophoresis
experiments were performed again to determine if ribosomes from resistant
strains (r/r and r/o) synthesized longer polyphenylalanine peptides than
ribosomes from the sensitive strain (+/+) in the presence of crypto-
pleurine. The products of ribosomes from the heterozygous strain (r/+)
also were examined to determine if they synthesized polyphenylalanine of
intermediate size.-
To examine the size of the -^H-polyphenylalanine synthesized in
-4
vitro in the presence of 1 x 10 M cryptopleurine, electrophoresis
.samples were prepared as described above. The molecular weight dis^
tributions of H-polyphenylalanine are illustrated in Figure 7. The
patterns observed for H-polyphenylalanine synthesized by ribosomes from
each of the strains possessing at least one r allele (r/r, r/+ and r/o)
were of similar sizes, heterogeneous, and indicate high molecular weight
polyphenylalanine (9000 to 65,000 daltons) . Ribosomes from the sensitive
strain (+/+) synthesized nothing longer than oligopeptides and con-
siderably less polyphenylalanine. Thus the sensitive ribosomes were not
blocking other ribosomes progressing along the polyuridylic acid.
Data from the experiments described above and data for growth of
cryptopleurine mutants on gradient plates (Meade, Riley and Manney (16))
are summarized in Table 7. From the gradient plate results and the
39
Figure 7. Electrophoresis of 3H-polyphenylalanine. Electrophoresis
samples" were prepared and analyzed as described in the
text. Protein standards are described in Fig. 5 with an
additional standard, insulin (I), 5,700 daltons. The
total number of 3H-cpm incorporated into polyphenylalanine
were for +/+, 1.384 x 10
4 (#) ; for r/r, 4.42 x 104 ;
for r/+, 4.86 x 104 A); and for r/o, 3.73 x 104 <'# .
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results of protein synthesis in spheroplasts, it is apparent that
resistance to cryptopleurine in vivo depends on the ratio of cryl
alleles to ploidy. The results of in vitro polyphenylalanine synthesis
tests indicate that the presence of at least one r allele confers
resistance to the ribosomes in these assays. The gel electrophoresis
data of protein synthesized in vivo by spheroplasts and polyphenylalanine
synthesized in_ vitro show that the three strains possessing at least
one resistant allele synthesize similar amounts and sizes of protein.
The sensitive strain synthesizes significantly less protein than the
other strains, but it synthesizes the same size protein as the strains
possessing one or more resistance allele. These results seem incon-
sistant and warrent explanation by a molecular model of cryptopleurine
resistance in diploid yeast strains.
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DISCUSSION
The object of this thesis was to further investigate the effects
of gene dosage on the inhibition of protein synthesis by cryptopleurine
in the yeast Saccharomyces cerevisiae . Resistance to cryptopleurine in
diploid and higher ploidy yeast strains has been shown to depend not on
the recessive or dominate character of the cryl gene but on the ratio of
cryl alleles to ploidy (16) . This unique form of genetic control was
especially obvious in the monosomic diploid strains (r/o) which possessed
only intermediate resistance to cryptopleurine on gradient agar plates.
Protein synthesis was studied to quantitate the rates of protein
synthesis in vivo in spheroplasts and to determine the resistance to
cryptopleurine of ribosomes from several strains by in vitro polyphenyl-
alanine synthesis. In order to understand the genetic control of crypto-
pleurine inhibition of protein synthesis in yeast, it is necessary to
understand the transfer of information from the gene to the polypeptide
and the basic steps of protein biosynthesis.
The genetic continuity of living organisms consists of three basic
parts: 1) replication of the genetic material deoxyribonucleic acid
(DNA) , 2) transcription of the genetic information in DNA to the messenger
ribonucleic acid (mRNA) , 3) and translation of the mRNA into protein.
Replication of the DNA is accomplished by a precise unfolding of the
template DNA helix and duplication of its nucleic acid base chains.
Transcription is accomplished when the template DNA unfolds and each DNA
base is paired with its complimentary RNA base forming an mRNA that
carries the genetic information of the DNA. The genetic code is triplicate
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and therefore three specific RNA bases form a codon for each of the
twenty amino acids used to produce the proteins. A given protein
consists of a unique linear sequence of amino acids. The ribosome is
the site of protein synthesis where the mRNA is "read" one triplet
codon at a time, and the transfer ribonucleic acid (tRNA) with its
matching anticodon delivers the specified amino acids necessary to
synthesize protein. For example, the artificial mRNA polyuridylic acid
(poly U) is translated by ribosomes into polyphenylalanine, indicating
that the triplicate mRNA codon for the amino acid phenylalanine is UUU.
Eucaryotic ribosomes have a sedimentation coefficient of 80S and
consist of two subunits, a large 60S subunit and a smaller 40S subunit.
Protein synthesis begins with the formation of an initiation complex.
The 40S subunit binds to the initiator tRNA through the action of
metf
the initiation factor 2 (IF2) (27) and the hydrolysis of guanosine
triphosphate (GTP) . The mRNA is attached through the action of the
initiation factor 3 (IF3) and the initiation factor 1 (IF1) , although
ill-defined, is thought to stabilize the initiation complex. The
initiation complex then associates with the 60S subunit to form the
intact ribosome. The large subunit possesses two sites, the peptidyl
site (P site) and the aminoacyl site (A site) (see Figure 8) . When the
two subunits associate, the initiator, methionyl-tRNA, binds to the P
site and the mRNA is positioned such that initiator codon is aligned
with the met-tRNA anticodon. Next the aminoacylated tRNA specified in
the mRNA binds to the A site positioning its anticodon with the next mRNA
codon. This reaction is dependent on elongation factor 1 (EF1) and GTP.
At this point, the methionine group bound to the tRNA at the P site
45
Figure 8. General model of a ribosome,
46
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leaves the tRNA and forms a peptide bond with the amino acid attached
to the tRNA at the A site. This peptidyl transfer reaction is catalyzed
by the enyzme peptidyl transferase, which is an integral part of the
60S ribosomal subunit. Translocation is the next step in protein
synthesis and involves two simultaneous events, the di-peptidyl-tRNA
shifts from the A site to the P site dislodging the tRNA and the ribosome
moves to the next codon of the mRNA. This step depends upon the presence
of elongation factor 2 (EF2) and GTP. Elongation then procedes in a
cyclic process. When the ribosome has proceded sufficiently along the
mRNA, other ribosomes can attach, forming a polysome. Protein synthesis
is terminated when the ribosome reaches a termination codon on the mRNA
and this reaction requires several termination factors.
Most studies of protein synthesis in_ vitro use synthetic polymers
such as polyuridylic acid as mRNA which lacks an initiator codon. High
(Mg ) are required for efficient translation of these messages and
there is no requirement for the initiation factors required for protein
synthesis in_ vivo . The ribosomes attach to the poly U and procede to
elongate the polypeptide as described above. In yeast, however, in
addition to EF1 and EF2, there is an elongation factor 3 (EF3) that is
a ribosome-dependent GTPase and is required for polyphenylalanine
synthesis (26) . The ribosomes continue to the end of the poly U, release
the polyphenylalanine, and dissociate into their component subunits.
Polyphenylalanine synthesis is inhibited by cryptopleurine by pre-
vention of 3H-Phe incorporation into polypeptide (2, 4, 7, 8, 10, 22, 25).
The drug also has been described as inhibiting the elongation of nascent
polypeptide as measured by amino acid incorporation (1, 8, 12, 22).
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Through puromycin reaction assays the peptidyl transfer step was impli-
cated to be the site of inhibition by one investigator (1) at very high
concentration while other investigators have indicated that translocation
is the site of inhibition (1, 4, 8, 12, 22). Further evidence that
translocation is the step inhibited by cryptopleurine is that Barbacid,
Fresno and Vazquez (1) observed that cryptopleurine inhibited the step
in translocation which requires EF2, and Bucher and Skogerson (4) found
that EF2 and GTP competitively inhibit cryptopleurine' s effect on trans-
location.
Although it is believed that cryptopleurine inhibits translocation,
no specific binding site for the drug has been identified. Crypto-
pleurine binds to yeast 80S ribosomes (2, 4, 10) and to isolated 40S
and 60S yeast ribosomal subunits, but since it binds to ribosomes in an
amount proportional to the cryptopleurine concentration, there does not
seem to be a saturable ribosomal binding site for the drug (4). One
investigator observed that cryptopleurine acted specifically on the
yeast 60S subunit when tested at very high concentrations (2) while
others (4, 7, 8, 22, 25) reported that the 40S subunit was the site of
cryptopleurine resistance in mutant strains of yeast. Investigators
also found 40S subunits from the mutant cryptopleurine resistant strains
to be less stable than those from cryptopleurine sensitive strains
(4, 7, 8, 25). Buchner and Skogerson (4) suggested that cryptopleurine
either binds to the 40S subunit or it effects the association of the
40S and 60S subunits since the 40S subunit is the site of cryptopleurine
resistance and the 60S subunit is the site of translocation.
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The experiments reported in this thesis were performed to investigate
the effects of gene dosage on cryptopleurine inhibition of protein
synthesis in diploid strains of the yeast Saccharomyces cerevisiae . The
protein synthesis studies in spheroplasts and in vitro with ribosomes
were conducted to determine the sensitivities to cryptopleurine of the
various mutants. Protein synthesized by spheroplasts and polyphenyl-
alanine synthesized with ribosomes were analyzed by gel electrophoresis
to determine if the protein synthesized by the various strains in the
presence of cryptopleurine varied in size. From the data in Table 7,
it is apparent that there are two types of resistance to cryptopleurine
in these mutants: 1) in in vitro polyphenylalanine synthesis ribosomes
from strains that possess at least one resistance allele were indis-
tinguishable by this assay and were more resistant to cryptopleurine than
were sensitive ribosomes, and 2) growth on gradient agar plates and
protein synthesis in spheroplasts, in vivo resistance to cryptopleurine
depended on the ratio of cryl alleles/ploidy. An explanation for the
genetic control of cryptopleurine resistance must account for both the
differences in the in vivo and in vitro assays and the results obtained
using these assays. From the data, several molecular models for the
basis of cryptopleurine resistance seem unlikely and therefore a model
is discussed that suggests the existence of another locus, not on
chromosome III, that regulates cryptopleurine resistance.
It has been suggested (16) that the cryl locus might code for a
component of the 40S ribosomal subunit that causes the mutant ribosome
to be resistant to cryptopleurine. This hypothesis predicts that yeast
strains possessing only r alleles (r/r, r/o and r) would produce resistant
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ribosomes with altered 40S ribosomal subunits and would be resistant
to the drug. It also predicts that sensitive strains would produce
normal ribosomes with unaltered 40S ribosomal subunits and they would
be sensitive to cryptopleurine. The heterozygous diploid (r/+) would
be expected to produce either a mixture of sensitive and resistant
ribosomes, or hybrid ribosomes. If the r/+ strain produced a mixture
of ribosomes it would possess an intermediate resistance that would
depend on the percentage of resistant ribosomes. If the heterozygote
(r/+) produced hybrid ribosomes, it would possess an intermediate
resistance that would depend on the inherent resistance of the hybrid
ribosomes. The hypothesis that a structural alteration of the 40S
subunit causes a strain to be resistant to the drug does not account for
these experiments in a straight forward manner since the heterozygous
diploid (r/+) produced ribosomes that were fully resistant to crypto-
pleurine in cell-free synthesis of polyphenylalanine (Table 7) . The
data from protein synthesis in spheroplasts (Table 7) also conflicts
with the above hypothesis since the monosomic diploid strain (r/o) was
more sensitive to cryptopleurine than was the homozygous diploid strain
(r/r) . From these results, the basis for cryptopleurine resistance
appears not to involve an alteration in the structure of the ribosome
alone.
If cryptopleurine resistance in yeast is not caused by a structural
alteration in the ribosome, it might be affected by a variation in
resistant ribosome concentrations in cells of the same ploidy. All
the diploid cells should have the same ribosome concentration. The
monosomic diploid (r/o) might have possessed fewer ribosomes than the
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fully diploid strains (r/r, r/+ and +/+) . If this were the case, then
the level of resistance exhibited by strains might have been proportional
to the number of resistant ribosomes per cell. The r/+ and r/o strains
might have been expected to display equal levels of resistance, since
they could contain the same concentration of resistant ribosomes,
although the r/+ strain might possess a greater number of ribosomes in
toto . Meade, Riley and Manney (16) have shown that ratios of mean cell
volume to ploidy in all the diploid strains tested were comparable and
therefore that the strains contained the same number of cells per gram
wet weight. As shown in Table 7, the amount of ribosomes per gram of
cells (and therefore per given number of cells) was only slightly less
for the monosomic diploid (r/o) than for the other strains. But as was
mentioned before, the r/o strain produced 76% as many ribosomes as did
the r/r strain and 87% as many as did the r/+ strain. Since the r/o
strain should produce only resistant ribosomes, spheroplasts prepared
from the r/o strain should be 76% as resistant as spheroplasts prepared
from the r/r strain. The results from the test of protein synthesis
in spheroplasts showed the r/o strain to be much less resistant than
the r/r strain and therefore different concentrations of resistant
ribosomes per cell alone can not account for the monosomic diploid's
(r/o) lower resistance to cryptopleurine.
Since the various resistances to cryptopleurine are difficult to
explain simply by an alteration of ribosomal structure or by the con-
centration of resistant ribosomes per cell, resistance may be affected
by an interaction between the cryl gene product and the products of one
or more other loci not on chromosome III. Two types of genetic control
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that involve multiple gene loci are complimentary and polymeric control.
In complementary gene control, there are several loci, each that codes
for a different enzyme required for synthesis of an amino acid. A
mutation at any one of these loci causes the strain to be auxotrophic
for that amino acid, but two strains deficient for different enzymes
can mate and complement the other strain's deficiency.
In polymeric control there are several unlinked genes that produce
identical or nearly identical products. If one of the loci is deficient,
the other loci may compensate by producing more product. A deficiency
in one of the loci may also interfere with or affect the product of the
other loci. Meade, Riley and Manney (16) reported a cryptopleurine
resistant mutant that appeared to require two genes for the expression
of its mutant phenotype. Neither of these genes appeared to be linked
to MAT1 and to cryl , both on chromosome III. The existence of more than
one gene that regulates a given phenotype is feasible, since Saccharomyces
cerevisiae possesses 4 unlinked genes that control maltose fermentation
and 5 to 7 unlinked genes for the production of each tRNA (6)
.
In order to understand the differing results obtained in in_ vivo
protein synthesis in spheroplasts and in in vitro polyphenylalanine syn-
thesis, the differences between the two types of assays must be considered.
Polyphenylalanine synthesis used high (Mg++) and a poly U message. This
assay did not initiate or terminate in the normal fashion and was there-
fore a measure of elongation. The elongation factors in this assay were
obtained from the sensitive diploid and thus resistance to cryptopleurine
can be attributed to the ribosomes.
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Protein synthesis in vivo in spheroplasts used nascent mRNA and
since the (Mg++) was naturally low the message was initiated, elongated,
and terminated through the natural sequence. Cryptopleurine resistance
in spheroplasts can not be attributed rigorously to the ribosomes since
the elongation factors used were the ones inherent to each strain.
Previous investigators found (8, 25) that elongation factors were not
involved in cryptopleurine resistance in haploids when measured by
polyphenylalanine synthesis, but it is not known whether elongation
factors influence cryptopleurine resistance in vivo .
A model consistant with the data presented is that a gene on a
chromosome other than chromosome III, denoted crym for cryptopleurine
modifier, produces a component of the P site on the 60S ribosomal
subunit or one of the initiation factors. The cryl locus produces
40S ribosomal subunits that are more resistant to cryptopleurine.
The presence of a sensitive allele (+) at the cryl locus therefore,
is not the presence of sensitive 40S subunits coded by that locus, but
the lack of resistant subunits. Other loci then code for both normal
ribosomal subunits. During initiation of protein synthesis there is
possibly a competition between the resistant 40S ribosomal subunits
modified by the cryl gene product and the normal 40S subunits for the
60S subunits or the initiation factors produced by the crym locus.
This model predicts that in in vitro polyphenylalanine synthesis
experiments, where elongation is the only protein synthesis step
measured, the ribosomes from the strains with at least one r allele
would be more resistant to cryptopleurine. In the tests of poly U
directed polyphenylalanine synthesis (Figure 6) the ribosomes from the
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strains with at least one r allele possessed equal resistance and were
more resistant than ribosomes from the sensitive strain.
In in vivo protein synthesis experiments initiation and elongation
are both measured by the incorporation of radioactive amino acids.
Resistance to cryptopleurine could be a mixture of resistance due to the
resistant 40S subunit in the elongation step and interaction of . the
resistant subunit with 60S subunits or initiation factors in the
initiation step of protein synthesis. The resistant 40S subunit could
interact with either an initiation factor or the P site on the 60S subunit,
where the initiator tRNA is initially placed, and cause the complex to
be more resistant to cryptopleurine during initiation. While the strains
that contain at least one r allele produce resistant 40S subunits and
elongate protein in the presence of cryptopleurine these subunits are
also important in causing resistance to cryptopleurine during initiation.
The r/+ and r/o strains, with a ratio of cryl alleles/ploidy of 0.5,
have fewer resistant ribosomes to complex with the initiation factors
or 60S subunits than the r/r or r strains and are therefore less re-
sistant. The resistance to cryptopleurine in initiation could depend
on the ratio of cryptopleurine resistance ribosomes to the amount of
initiation factors or 60S subunits.
The crym model also predicts that in vitro the strains possessing
a cryl allele and therefore resistant ribosomes should produce the same
size and more peptide than ribosomes from the sensitive strain. This is
supported by Figure 7 where the proteins synthesized by the ribosomes in
the presence of cryptopleurine were of the same size, but the sensitive
strain produced considerably less protein. This model predicts that
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in vivo the strains possessing an r allele would elongate protein better
and produce more protein, but that the r/r strain should initiate better
and produce more peptide than the r/+ and r/o strains. In Figure 5, the
strains with one r allele did produce the same size and more protein,
but the yields for the r/r, r/+ and r/o strains were comparable. This
may be due to the excess 3H-Leu added and the longer pulse time, used to
produce proteins for gel electrophoresis. The resistance to cryptopleurine
is probably produced by a complex balance of initiation and elongation
resistances and is affected by experimental conditions.
Previous investigators (8, 11, 24) had ruled out initiation as a
site of cryptopleurine action since polysome sucrose gradient profiles
from sensitive strains did not change in the presence of cryptopleurine.
When a strain is inhibited at the initiation step, its polysomes profile
degrades to single ribosomes. But if elongation and initiation were
affected, the ribosomes would be "frozen" on the message and the
defect in initiation would not be distinguishable. Cryptopleurine
therefore might affect initiation as well as elongation measured in
these tests.
These results indicate that cryptopleurine resistance in yeast may
be controlled by more than one genetic locus. Experiments to isolate
and investigate alternate cryptopleurine mutants at the crym locus are
necessary for further development of a molecular model of cryptopleurine
resistance. It would also be useful to know if haploid strains disomic
for chromosome III, and therefore possessing a cryl/ploidy ratio of 2,
are more resistant than strains possessing a ratio of 1. Cryptopleurine
resistance in yeast continues to provide an interesting system for
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analyzing some effects of gene dosage on the inhibition of protein
synthesis in yeast.
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APPENDIX I
Nomenclature For Genetic Markers
Nutritional Requirement Symbol
Adenine ade
Leucine leu
Lysine lys
Methionine met
Histidine his
Threonine thr
Tryptophan trp
Uracil ura
Others:
Cryptopleurine (resistance) cry
Galactose (loss of fermentation
ability) gal
Mating Type
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Inhibition of protein synthesis by cryptopleurine was studied in
spheroplasts from the yeast Saccharomyces cerevisiae and with purified
yeast ribosomes in polyuridylic acid directed polyphenylalanine synthesis
in order to better understand the genetic regulation of cryptopleurine
resistance. A monosomic diploid strain possessing one cryptopleurine
resistance allele was of special interest since it was not resistant to
crytopleurine on agar plates containing a gradient of cryptopleurine
concentrations.
Rates of protein synthesis were quantitated in spheroplasts from
several strains of yeast, including the monosomic diploid. The yeast
strains expressed various resistances to cryptopleurine such that
strains with a higher ratio of cryl-7 alleles to ploidy were more
resistant than strains with lower ratios. Strains with similar ratios
displayed similar levels of resistance to the drug.
Cryptopleurine inhibition of polyphenylalanine synthesis was
«
studied in vitro using soluble elongation factors prepared from the
sensitive diploid strain. The ribosomes used in the study were pre-
pared from the sensitive diploid strain, a resistant diploid strain,
a heterozygous diploid strain, and a monosomic diploid strain. Ribosomes
obtained from all strains possessing at least one resistant allele were
indistinguishable from each other by this assay and were more resistant
to cryptopleurine than were ribosomes from the sensitive strain.
A model is discussed that suggests the existence of a locus not on
chromosome III whose product interacts with the cryl gene product to
affect the expression of cryptopleurine resistance in yeast.
